Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (411-420 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Cardiology|October 12, 2000
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarctionY Birnbaum, G S Wagner, K B Gates, et al.
The American Journal of Cardiology|December 1, 1986
Prognostic implications of angiographically normal and insignificantly narrowed coronary arteriesM N Papanicolaou, R M Califf, M A Hlatky, et al.
Circulation|December 1, 1989
Exercise treadmill testing is a poor predictor of anatomic restenosis after angioplasty for acute myocardial infarctionM B Honan, J R Bengtson, D B Pryor, et al.
Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.
Circulation|April 13, 1999
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams, C A Sueta, M Gheorghiade, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1996
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery diseaseR H Jones, K Kesler, H R Phillips, et al.
Circulation|December 22, 1998
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart diseaseD F Kong, R M Califf, D P Miller, et al.
Circulation|September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I InvestigatorsR M Califf, H D White, F Van de Werf, et al.
Coronary Artery Disease|November 1, 1993
An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study GroupE M Ohman, E J Topol, R M Califf, et al.
The New England Journal of Medicine|September 3, 1987
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
Pageof 57

Showing results (411-420 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Cardiology|October 12, 2000
Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarctionY Birnbaum, G S Wagner, K B Gates, et al.
The American Journal of Cardiology|December 1, 1986
Prognostic implications of angiographically normal and insignificantly narrowed coronary arteriesM N Papanicolaou, R M Califf, M A Hlatky, et al.
Circulation|December 1, 1989
Exercise treadmill testing is a poor predictor of anatomic restenosis after angioplasty for acute myocardial infarctionM B Honan, J R Bengtson, D B Pryor, et al.
Circulation|September 12, 2001
Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trialsM P Hudson, C B Granger, E J Topol, et al.
Circulation|April 13, 1999
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams, C A Sueta, M Gheorghiade, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1996
Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery diseaseR H Jones, K Kesler, H R Phillips, et al.
Circulation|December 22, 1998
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart diseaseD F Kong, R M Califf, D P Miller, et al.
Circulation|September 15, 1996
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I InvestigatorsR M Califf, H D White, F Van de Werf, et al.
Coronary Artery Disease|November 1, 1993
An analysis of the cause of early mortality after administration of thrombolytic therapy. The Thrombolysis Angioplasty in Myocardial Infarction Study GroupE M Ohman, E J Topol, R M Califf, et al.
The New England Journal of Medicine|September 3, 1987
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarctionE J Topol, R M Califf, B S George, et al.
Pageof 57